ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 119 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,405,049 | +142583.2% | 645,020 | 0.0% | 0.02% | +43.8% |
| Q4 2022 | $4,489 | -99.9% | 645,020 | -0.1% | 0.02% | +23.1% |
| Q3 2022 | $3,447,000 | +33.6% | 645,470 | -0.2% | 0.01% | +30.0% |
| Q2 2022 | $2,581,000 | -40.4% | 646,817 | -33.7% | 0.01% | -16.7% |
| Q1 2022 | $4,334,000 | +3988.7% | 975,139 | +3594.8% | 0.01% | – |
| Q4 2021 | $106,000 | -82.6% | 26,392 | -61.9% | 0.00% | -100.0% |
| Q3 2021 | $608,000 | -91.6% | 69,219 | -89.2% | 0.00% | -92.0% |
| Q2 2021 | $7,232,000 | +1031.8% | 638,313 | +1087.0% | 0.02% | +733.3% |
| Q1 2021 | $639,000 | -65.4% | 53,774 | -80.0% | 0.00% | -62.5% |
| Q4 2020 | $1,847,000 | -47.4% | 269,183 | -43.2% | 0.01% | -60.0% |
| Q3 2020 | $3,514,000 | – | 474,276 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,031,915 | $20,253,192 | 21.02% |
| Perceptive Advisors | 11,350,085 | $75,818,568 | 2.53% |
| JOHNSON & JOHNSON | 394,834 | $2,637,491 | 0.97% |
| Joseph P. Lucia & Associates, LLC | 28,331 | $189,251 | 0.13% |
| WOODSTOCK CORP | 137,179 | $916,356 | 0.12% |
| Palo Alto Investors LP | 160,800 | $1,074,144 | 0.10% |
| Affinity Asset Advisors, LLC | 44,348 | $296,245 | 0.08% |
| Verition Fund Management LLC | 935,273 | $6,247,624 | 0.07% |
| FOX RUN MANAGEMENT, L.L.C. | 33,519 | $223,907 | 0.07% |
| TOBIAS FINANCIAL ADVISORS, INC. | 34,173 | $228,276 | 0.06% |